Drug Type Small molecule drug |
Synonyms Tolenix, Tolterodine/pilocarpine, THVD-201 + [1] |
Mechanism M2 receptor antagonists(Muscarinic acetylcholine receptor M2 antagonists), M3 receptor antagonists(Muscarinic acetylcholine receptor M3 antagonists), mAChRs agonists(Muscarinic acetylcholine receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H17ClN2O2 |
InChIKeyRNAICSBVACLLGM-GNAZCLTHSA-N |
CAS Registry54-71-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Bladder, Overactive | Phase 3 | KR | - | |
Urinary Incontinence | Phase 1 | - | 01 Sep 2009 |